Bartsch, Rupert http://orcid.org/0000-0002-4384-6917
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 16 October 2023
Accepted: 2 November 2023
First Online: 5 December 2023
Conflict of interest
: R. Bartsch: <i>Advisory role</i>: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Seagen, Stemline; <i>lecture honoraria</i>: Astra-Zeneca, BMS, Daichi, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen; <i>research support</i>: Daiichi, MSD, Novartis, Roche.